COMP <GO>
NOC vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
Northrop Grumman Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: NOC 6
— TMO 5
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TMO
LAST: $562.36 (+1.74%) • MKT CAP: $79.89B
balance-sheet
2.97
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NOC VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NOC | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.00% | 9.30% | +3.70 | NOC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.8x | 30.4x | -14.60 | NOC | /valuation <GO> |
| Free Cash Flow Yield | 4.14% | 2.40% | +1.74 | NOC | /fcf-yield <GO> |
| Operating Margin | 10.80% | 17.40% | -6.60 | TMO | /operating-margins <GO> |
| Net Profit Margin | 10.00% | 15.10% | -5.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 2.20% | 3.90% | -1.70 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.62% | 0.24% | +1.38 | NOC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.97 | 4.50 | -1.53 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.5 | 62.9 | +2.60 | NOC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.94 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.8x | 36.3x | -18.50 | NOC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $79.89B | $262.22B | -$182.33B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NOC REV | TMO REV | NOC GROSS % | TMO GROSS % | NOC FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $41.95B | $44.56B | — | — | $3.31B | $6.29B |
| FY 2024 | $41.03B | $42.88B | — | — | $2.62B | $7.27B |
| FY 2023 | $39.29B | $42.86B | — | — | $2.11B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NOC // BETA 0.94
TMO // BETA 0.94